GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $438,000 | +21.7% | 9,974 | +22.3% | 0.04% | +42.3% |
Q1 2022 | $360,000 | -17.4% | 8,156 | -16.4% | 0.03% | +4.0% |
Q4 2021 | $436,000 | +19.5% | 9,760 | +3.5% | 0.02% | +13.6% |
Q3 2021 | $365,000 | +15.1% | 9,429 | +19.9% | 0.02% | +10.0% |
Q2 2021 | $317,000 | +41.5% | 7,864 | +27.7% | 0.02% | +25.0% |
Q1 2021 | $224,000 | -28.2% | 6,159 | -26.4% | 0.02% | -30.4% |
Q4 2020 | $312,000 | -2.2% | 8,373 | +0.1% | 0.02% | -17.9% |
Q3 2020 | $319,000 | +14.3% | 8,361 | +23.6% | 0.03% | +3.7% |
Q2 2020 | $279,000 | -37.9% | 6,767 | -42.1% | 0.03% | -44.9% |
Q1 2020 | $449,000 | -17.5% | 11,681 | +1.7% | 0.05% | -9.3% |
Q4 2019 | $544,000 | +114.2% | 11,482 | +94.5% | 0.05% | -14.3% |
Q3 2019 | $254,000 | -36.7% | 5,903 | -41.1% | 0.06% | +53.7% |
Q2 2019 | $401,000 | +63.7% | 10,020 | +72.5% | 0.04% | +64.0% |
Q1 2019 | $245,000 | +18.4% | 5,810 | +8.2% | 0.02% | 0.0% |
Q4 2018 | $207,000 | +16.3% | 5,368 | +20.9% | 0.02% | -50.0% |
Q3 2018 | $178,000 | – | 4,439 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 9,016,970 | $392,735,000 | 43.50% |
Black Creek Investment Management Inc. | 9,208,599 | $401,127,000 | 11.30% |
KAHN BROTHERS GROUP INC | 1,426,664 | $62,145,788,000 | 7.89% |
Eversept Partners, LP | 1,553,700 | $67,679,172 | 5.20% |
EQUITY INVESTMENT CORP | 3,050,561 | $132,882,000 | 4.54% |
JET CAPITAL INVESTORS L P | 635,000 | $27,661,000 | 4.34% |
Eversept Partners, LP | 1,259,162 | $55,533,447 | 4.26% |
CLIFFORD CAPITAL PARTNERS LLC | 160,568 | $6,994,000 | 3.77% |
NKCFO LLC | 269,500 | $11,739,000 | 3.65% |
Keystone Financial Planning, Inc. | 233,912 | $10,189,000 | 3.41% |